Metropolitan Life Insurance Company (MetLife)’s AbbVie ABBV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,209	Closed	-$13M	–	16
2024 Q1	$13M	Sell	71,209 -656	-0.9%	-$113K	0.56%	27
2023 Q4	$11.1M	Sell	71,865 -1,162	-2%	-$169K	0.52%	27
2023 Q3	$10.9M	Sell	73,027 -3,859	-5%	-$567K	0.57%	27
2023 Q2	$10.4M	Sell	76,886 -2,214	-3%	-$325K	0.5%	30
2023 Q1	$12.6M	Sell	79,100 -19,035	-19%	-$2.91M	0.65%	24
2022 Q4	$15.9M	Sell	98,135 -5,111	-5%	-$784K	0.71%	25
2022 Q3	$13.9M	Sell	103,246 -1,181	-1%	-$169K	0.66%	25
2022 Q2	$16M	Sell	104,427 -2,668	-2%	-$408K	0.7%	24
2022 Q1	$17.4M	Sell	107,095 -175,412	-62%	-$25.5M	0.62%	25
2021 Q4	$38.3M	Sell	282,507 -5,938	-2%	-$701K	0.52%	24
2021 Q3	$31.1M	Sell	288,445 -9,453	-3%	-$1.08M	0.45%	31
2021 Q2	$33.6M	Sell	297,898 -3,949	-1%	-$445K	0.47%	24
2021 Q1	$32.7M	Sell	301,847 -17,361	-5%	-$1.86M	0.49%	25
2020 Q4	$34.2M	Sell	319,208 -14,009	-4%	-$1.35M	0.51%	28
2020 Q3	$29.2M	Sell	333,217 -13,198	-4%	-$1.24M	0.49%	31
2020 Q2	$34M	Buy	346,415 +56,930	+20%	+$5.01M	0.6%	23
2020 Q1	$22.1M	Sell	289,485 -4,127	-1%	-$352K	0.45%	39
2019 Q4	$26M	Sell	293,612 -1,590	-0.5%	-$132K	0.42%	41
2019 Q3	$22.4M	Sell	295,202 -1,930	-0.6%	-$132K	0.38%	49
2019 Q2	$21.6M	Buy	297,132 +13,584	+5%	+$1.07M	0.36%	48
2019 Q1	$22.9M	Sell	283,548 -12,661	-4%	-$1.04M	0.41%	36
2018 Q4	$27.3M	Sell	296,209 -538	-0.2%	-$47.3K	0.55%	32
2018 Q3	$28.1M	Sell	296,747 -12,746	-4%	-$1.21M	0.48%	33
2018 Q2	$28.7M	Sell	309,493 -7,542	-2%	-$737K	0.46%	38
2018 Q1	$30M	Buy	317,035 +1,429	+0.5%	+$157K	0.42%	34
2017 Q4	$30.5M	Sell	315,606 -512,855	-62%	-$48.3M	0.41%	33
2017 Q3	$73.6M	Sell	828,461 -5,404	-0.6%	-$411K	0.46%	38
2017 Q2	$60.5M	Sell	833,865 -16,917	-2%	-$1.14M	0.42%	44
2017 Q1	$55.4M	Sell	850,782 -26,363	-3%	-$1.66M	0.38%	45
2016 Q4	$54.9M	Sell	877,145 -30,071	-3%	-$1.84M	0.39%	42
2016 Q3	$57.2M	Sell	907,216 -5,680	-0.6%	-$368K	0.42%	42
2016 Q2	$56.5M	Sell	912,896 -8,118	-0.9%	-$495K	0.42%	47
2016 Q1	$52.6M	Sell	921,014 -26,679	-3%	-$1.49M	0.4%	45
2015 Q4	$56.1M	Sell	947,693 -15,420	-2%	-$888K	0.43%	41
2015 Q3	$52.4M	Sell	963,113 -56,789	-6%	-$3.7M	0.38%	46
2015 Q2	$68.5M	Buy	1,019,902 +83,559	+9%	+$5.46M	0.48%	38
2015 Q1	$54.8M	Sell	936,343 -11,390	-1%	-$688K	0.4%	49
2014 Q4	$62M	Sell	947,733 -2,531	-0.3%	-$160K	0.43%	42
2014 Q3	$54.9M	Sell	950,264 -14,468	-1%	-$803K	0.39%	43
2014 Q2	$54.4M	Sell	964,732 -43,321	-4%	-$2.27M	0.38%	43
2014 Q1	$51.8M	Sell	1,008,053 -16,902	-2%	-$854K	0.36%	51
2013 Q4	$54.1M	Sell	1,024,955 -16,658	-2%	-$819K	0.38%	47
2013 Q3	$46.6M	Sell	1,041,613 -7,331	-0.7%	-$325K	0.36%	47
2013 Q2	$43.4M	Buy	+1,048,944	New	+$45.9M	0.35%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Metropolitan Life Insurance Company (MetLife)'s ABBV Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 71,209 shares — an estimated $13M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ABBV in Q2 2013 and held it in 44 quarters. The position peaked at $73.6M in Q3 2017. 3,367 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 71,209 AbbVie shares in Q2 2024, an estimated $13M.
Metropolitan Life Insurance Company (MetLife) first reported a position in AbbVie in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s AbbVie position peaked at $73.6M in Q3 2017.
3,367 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.